Sr One Capital Management, Lp Top Holdings and 13F Report (2024) → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) About Sr One Capital Management, LpInvestment ActivitySr One Capital Management, Lp has $364.09 million in total holdings as of March 31, 2024.Sr One Capital Management, Lp owns shares of 6 different stocks, but just 4 companies or ETFs make up 80% of its holdings.Approximately 26.36% of the portfolio was purchased this quarter.About 15.28% of the portfolio was sold this quarter.This quarter, Sr One Capital Management, Lp has purchased 5 new stocks and bought additional shares in 2 stocks.Sr One Capital Management, Lp sold shares of 1 stock and completely divested from 0 stocks this quarter.Largest Holdings Arcellx $163,208,117CRISPR Therapeutics $71,496,500ARS Pharmaceuticals $41,011,869Nkarta $36,033,330Design Therapeutics $26,301,698 Largest New Holdings this Quarter CRISPR Therapeutics $71,496,500 Holding Largest Purchases this Quarter CRISPR Therapeutics 1,048,951 shares (about $71.50M)Nkarta 2,000,000 shares (about $21.62M)Mineralys Therapeutics 222,222 shares (about $2.87M) Largest Sales this Quarter Arcellx 800,000 shares (about $55.64M) Sector Allocation Over TimeMap of 500 Largest Holdings ofSr One Capital Management, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorACLXArcellx$163,208,117$55,640,000 ▼-25.4%2,346,63044.8%MedicalCRSPCRISPR Therapeutics$71,496,500$71,496,500 ▲New Holding1,048,95119.6%MedicalSPRYARS Pharmaceuticals$41,011,8690.0%4,012,90311.3%MedicalNKTXNkarta$36,033,330$21,620,000 ▲150.0%3,333,3339.9%MedicalDSGNDesign Therapeutics$26,301,6980.0%6,526,4767.2%MedicalMLYSMineralys Therapeutics$26,037,172$2,868,886 ▲12.4%2,016,8227.2%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data: SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
